Respiratory FailureNCT03064659
Driving Pressure And EFL in Adult Cardiac Surgery
An observational study of Respiratory Failure and Pneumothorax, run by Ospedale San Raffaele at 1 site in Italy.
Trial summary
During general anesthesia, functional residual capacity (FRC) is reduced. If the FRC is lower than the minimum volume required to maintain the opening of the airways, there is a derecruitment of the lung parenchyma, leading to the phenomenon of expiratory flow limitation (EFL). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Respiratory Failure, Pneumothorax, Atelectasis
- How many people
- 200 participants
- Where
- 1 siteItaly
- Study dates
- Nov 2015to May 2017
- How long will I take part?
- 1 Month
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult Undergoing Elective Cardiac Surgery
Who may be able to join
- Age > 18 years old
- Ability to provide an informed consent
- Planned cardiac surgery with median sternotomy and bi-pulmonary ventilation
- patients scheduled for adult elective cardiac surgery, performed with CPB and aortic cross-clamping.
Who cannot join
- Patient refusal to provide informed consent
- Emergency surgery
- Cardiac surgery with TAVI/MitraClip
- Planned thoracotomy with one lung ventilation
- Patients with chronic kidney insufficiency (defined as dialysis)
- Patients already intubated in the peri-operative period
- Patients with pneumonia in the pre-operative period (30 days before surgery)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Driving Pressure And Limitation of Expiratory Flow: Evaluation of Postoperative Pulmonary Complications in Elective Adult Cardiac Surgery.
During general anesthesia, functional residual capacity (FRC) is reduced. If the FRC is lower than the minimum volume required to maintain the opening of the airways, there is a derecruitment of the lung parenchyma, leading to the phenomenon of expiratory flow limitation (EFL).
The Driving Pressure (DP) is the difference between the plateau pressure (Pplateau) and the Positive End-Expiratory Pressure (PEEP), and estimates the lung strain.
Read more
The incidence of EFL and the importance of DP are not known in adult cardiac surgery, so it's necessary a study to assess both. The primary end-point of the study is to evaluate the correlation of DP and EFL with PPCs in adult cardiac surgery. The secondary end-point of the study is to evaluate: the mechanical ventilation time, the length of ICU and hospital stay, the rehospitalization and mortality.
It will be a prospective, observational, non-pharmacological study. It will enroll 200 patients undergoing elective adult cardiac surgery.
Read the detailed description
During general anesthesia, functional residual capacity (FRC) is reduced. If the FRC is lower than the minimum volume required to maintain the opening of the airways (closing capacity), there is a derecruitment of the lung parenchyma, leading to the phenomenon of expiratory flow limitation (EFL). Numerous factors contribute to the EFL, including hyperoxia, muscle paralysis, the increase of the volume of the interstitial fluids and the inflammatory response.
To establish the presence of EFL under general anesthesia, it was developed a test known as PEEP test. It is the sudden removal of 3 cm H2O to the value of positive end-expiratory pressure (PEEP test): in the EFL the subtraction of the expiratory pressure does not produce an increase of expiratory flow. The use of different modality of mechanical ventilation during cardiac surgery may impact on the incidence of EFL post CEC.
The Driving Pressure (DP) is the difference between the plateau pressure (Pplateau) and the Positive End-Expiratory Pressure (PEEP), and estimates the lung strain.
The primary end-point of the study will be:
- Evaluate the correlation of DP and EFL with PPCs in patients undergoing elective cardiac surgery performed with extracorporeal circulation.
The secondary end-point of the study will be:
- Consider whether there are factors associated with the development of EFL, especially comorbidities and ventilation mode during surgery;
- Evaluate outcomes such as duration of mechanical ventilation, length of stay in intensive care (ICU), PaO2/ FiO2 at discharge from the ICU, development of respiratory complications, duration of hospital stay and mortality.
It will be a prospective, observational, non-pharmacological study. It will enroll 200 patients undergoing elective adult cardiac surgery.
Respiratory rate will be set to maintain PaCO2 at values close to eucapnia. It will be used to pressure-controlled ventilation (Pinsp ≤ 35 cm H2O) only if the controlled ventilation is reached and exceed the maximum airway pressures. In this case it will be necessary to check that the volume delivered by the ventilator is really, for the entire period, the chosen volume. The inspiratory way will be composed of O2, air and maybe the halogenated anesthetic. The O2 concentration will be increased gradually in case of desaturation up to maintain SpO2 93-95% trying not to exceed the FiO2 of 0.8 if it will be choice a protective ventilation strategy.
Weaning from the CEC will include a single alveolar recruitment maneuver, in which the airway pressure will be increased to 40 cm H20 for 7 seconds.
At the end the patients will be transferred to the Intensive Care Unit (ICU) for post-operative monitoring. During the transfer will be supported with mechanical ventilation performed manually by the anesthetist resuscitator.
Extubation in ICU will run in according to the protocol of the center. It could be used any postoperative analgesia that provides NRS at rest ≤ 3 and dynamic NRS (cough) ≤ 4 and allow an active chest physical therapy (CPT).
The following information will be collected:
In the section devoted to the preoperative treats will be fit the patient data related to:
- Age, weight, height, sex;
- Comorbidities
- Positive respiratory history of: previous pleural-parenchymal disease within 30 days prior to the intervention, previous surgery of the thorax, pleura or lung, presence of pleural effusion;
- History of smoking cigarettes: Active smoking (number of cigarettes), ex-smoker or non-smoker;
- SpO2, PaO 2, PaO 2 / FiO 2, PaCo 2 (if available);
- Cardiological history (echocardiography, ECG, etc.)
- Other medical history information of relevance to the study
In the dedicated intraoperatory tab will be collected the following data:
- Incidence of EFL and respiratory mechanics parameters;
- Type of surgery;
- Time to CEC, clamping, cardioplegia, type of circuit and oxygenator;
- Transfusion of blood products;
- Any administration of cardio / vasoactive drugs;
- Duration of surgery;
- Other information relevant for the purposes of the study.
In the schedule about the post-operative treats will be collected the following data:
- Postoperative mechanical ventilation time;
- Postoperative respiratory complications;
- Postoperative non-respiratory complications (cardiovascular, infectious, kidney, surgical);
- The need for re-intubation in the postoperative period;
- The need for ventilatory support (non-invasive ventilation, invasive ventilation) in the postoperative period;
- Need for hospitalization in intensive care (expected, unexpected, cause of hospitalization, length of stay);
- Length of hospital stay;
- Other information about the postoperative relevant to the study The study does not interfere with the normal anesthetic activity, it does not provide for variations from the procedures currently used and the PEEP test use does not involve pathophysiological changes for the patient.
Data will be collected on the appropriate Case Report Form (CRF). It will be collected anamnestic information, data about surgery and post-operative clinical data, in particular respiratory parameters. Definitions and use of outcome measures are in according to the standards for European Perioperative Clinical Outcome (EPCO) definitions [Eur J Anaesthesiol 2015; 32:88-105].
Data will be analyzed with a professional statistical software. Univariate and multivariate analysis will be performed. Chi-square test will be used for dichotomous variables, z-test/t-test or the Mann-Whitney U-test for continuous variables, as appropriate. Statistical significance if p <0.05.
- Conditions
- Respiratory Failure, Pneumothorax, Atelectasis, Respiratory Infection, Bronchospasm, Pleural Effusion
- Keywords
- Postoperative pulmonary complications, Driving Pressure, Limitation of Expiratory Flow, Cardiac Surgery, Cardio-pulmonary bypass
- Medical subject headings
- Respiratory Insufficiency, Pneumothorax, Pulmonary Atelectasis, Respiratory Tract Infections, Bronchial Spasm, Pleural Effusion
What is being measured
The primary outcome is the main question the study is designed to answer.
Expiratory Flow Limitation
Measured: Through study completion, an average of 24 hours after surgery
Incidence of Driving Pressure
Measured: Through study completion, an average of 24 hours after surgery
Secondary outcomes (6)
Postoperative pulmonary complication
Respiratory Failure, Pneumothorax, Atelectasis, Respiratory Infection, Bronchospasm, Pleural Effusion
Measured: Through study completion, an average of 7 days after surgery
ICU length of stay
Measured: Through study completion, an average of 24 hours after surgery
Hospital length of stay
Measured: Through study completion, an average of 7 days after surgery
Duration of mechanical ventilation
Measured: Through study completion, an average of 7 days after surgery
PaO2/ FiO2
Measured: Through study completion, an average of 24 hours after surgery
Mortality
Measured: Through study completion, an average of 7 days after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Feb 2017
- Study startNov 2015
- Primary completionJan 2017
- Study completionMay 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Respiratory FailureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 200 participants (actual)
- Target duration
- 1 Month
Sponsor and investigators
- Lead sponsor
- Ospedale San Raffaele
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Elena Bignami, Ospedale San Raffaele
- Investigators
- Elena Bignami, MD, Principal investigator, Ospedale San Raffaele
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03064659
- Sponsor's protocol ID
- DPEFLCCH
- Status last verified
- May 2017
- First submitted
- 17 Feb 2017
- Last updated
- 23 May 2017
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Grieco DL, Chen L, Dres M, Brochard L. Should we use driving pressure to set tidal volume? Curr Opin Crit Care. 2017 Feb;23(1):38-44. doi: 10.1097/MCC.0000000000000377.
PubMed 27875410
Study at a glance
From the registry record, last updated by the sponsor on 23 May 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Driving Pressure And Limitation of Expiratory Flow: Evaluation of Postoperative Pulmonary Complications in Elective Adult Cardiac Surgery.
- ClinicalTrials.gov ID
- NCT03064659
- Acronym / sponsor ID
- DPEFLCCH
- Conditions
- Respiratory Failure, Pneumothorax, Atelectasis, Respiratory Infection, Bronchospasm, Pleural Effusion
- Keywords
- Postoperative pulmonary complications, Driving Pressure, Limitation of Expiratory Flow, Cardiac Surgery, Cardio-pulmonary bypass
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- Ospedale San RaffaeleUniversity, hospital or other
- Study start
- Nov 2015 (actual)
- Primary completion
- Jan 2017 (actual)
- Study completion
- May 2017 (actual)
- First posted
- 27 Feb 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
During general anesthesia, functional residual capacity (FRC) is reduced. If the FRC is lower than the minimum volume required to maintain the opening of the airways, there is a derecruitment of the lung parenchyma, leading to the phenomenon of expiratory flow limitation (EFL).
The Driving Pressure (DP) is the difference between the plateau pressure (Pplateau) and the Positive End-Expiratory Pressure (PEEP), and estimates the lung strain.
The incidence of EFL and the importance of DP are not known in adult cardiac surgery, so it's necessary a study to assess both. The primary end-point of the study is to evaluate the correlation of DP and EFL with PPCs in adult cardiac surgery. The secondary end-point of the study is to evaluate: the mechanical ventilation time, the length of ICU and hospital stay, the rehospitalization and mortality.
It will be a prospective, observational, non-pharmacological study. It will enroll 200 patients undergoing elective adult cardiac surgery.
Detailed description
During general anesthesia, functional residual capacity (FRC) is reduced. If the FRC is lower than the minimum volume required to maintain the opening of the airways (closing capacity), there is a derecruitment of the lung parenchyma, leading to the phenomenon of expiratory flow limitation (EFL). Numerous factors contribute to the EFL, including hyperoxia, muscle paralysis, the increase of the volume of the interstitial fluids and the inflammatory response.
To establish the presence of EFL under general anesthesia, it was developed a test known as PEEP test. It is the sudden removal of 3 cm H2O to the value of positive end-expiratory pressure (PEEP test): in the EFL the subtraction of the expiratory pressure does not produce an increase of expiratory flow. The use of different modality of mechanical ventilation during cardiac surgery may impact on the incidence of EFL post CEC.
The Driving Pressure (DP) is the difference between the plateau pressure (Pplateau) and the Positive End-Expiratory Pressure (PEEP), and estimates the lung strain.
The primary end-point of the study will be:
- Evaluate the correlation of DP and EFL with PPCs in patients undergoing elective cardiac surgery performed with extracorporeal circulation.
The secondary end-point of the study will be:
- Consider whether there are factors associated with the development of EFL, especially comorbidities and ventilation mode during surgery;
- Evaluate outcomes such as duration of mechanical ventilation, length of stay in intensive care (ICU), PaO2/ FiO2 at discharge from the ICU, development of respiratory complications, duration of hospital stay and mortality.
It will be a prospective, observational, non-pharmacological study. It will enroll 200 patients undergoing elective adult cardiac surgery.
Respiratory rate will be set to maintain PaCO2 at values close to eucapnia. It will be used to pressure-controlled ventilation (Pinsp ≤ 35 cm H2O) only if the controlled ventilation is reached and exceed the maximum airway pressures. In this case it will be necessary to check that the volume delivered by the ventilator is really, for the entire period, the chosen volume. The inspiratory way will be composed of O2, air and maybe the halogenated anesthetic. The O2 concentration will be increased gradually in case of desaturation up to maintain SpO2 93-95% trying not to exceed the FiO2 of 0.8 if it will be choice a protective ventilation strategy.
Weaning from the CEC will include a single alveolar recruitment maneuver, in which the airway pressure will be increased to 40 cm H20 for 7 seconds.
At the end the patients will be transferred to the Intensive Care Unit (ICU) for post-operative monitoring. During the transfer will be supported with mechanical ventilation performed manually by the anesthetist resuscitator.
Extubation in ICU will run in according to the protocol of the center. It could be used any postoperative analgesia that provides NRS at rest ≤ 3 and dynamic NRS (cough) ≤ 4 and allow an active chest physical therapy (CPT).
The following information will be collected:
In the section devoted to the preoperative treats will be fit the patient data related to:
- Age, weight, height, sex;
- Comorbidities
- Positive respiratory history of: previous pleural-parenchymal disease within 30 days prior to the intervention, previous surgery of the thorax, pleura or lung, presence of pleural effusion;
- History of smoking cigarettes: Active smoking (number of cigarettes), ex-smoker or non-smoker;
- SpO2, PaO 2, PaO 2 / FiO 2, PaCo 2 (if available);
- Cardiological history (echocardiography, ECG, etc.)
- Other medical history information of relevance to the study
In the dedicated intraoperatory tab will be collected the following data:
- Incidence of EFL and respiratory mechanics parameters;
- Type of surgery;
- Time to CEC, clamping, cardioplegia, type of circuit and oxygenator;
- Transfusion of blood products;
- Any administration of cardio / vasoactive drugs;
- Duration of surgery;
- Other information relevant for the purposes of the study.
In the schedule about the post-operative treats will be collected the following data:
- Postoperative mechanical ventilation time;
- Postoperative respiratory complications;
- Postoperative non-respiratory complications (cardiovascular, infectious, kidney, surgical);
- The need for re-intubation in the postoperative period;
- The need for ventilatory support (non-invasive ventilation, invasive ventilation) in the postoperative period;
- Need for hospitalization in intensive care (expected, unexpected, cause of hospitalization, length of stay);
- Length of hospital stay;
- Other information about the postoperative relevant to the study The study does not interfere with the normal anesthetic activity, it does not provide for variations from the procedures currently used and the PEEP test use does not involve pathophysiological changes for the patient.
Data will be collected on the appropriate Case Report Form (CRF). It will be collected anamnestic information, data about surgery and post-operative clinical data, in particular respiratory parameters. Definitions and use of outcome measures are in according to the standards for European Perioperative Clinical Outcome (EPCO) definitions [Eur J Anaesthesiol 2015; 32:88-105].
Data will be analyzed with a professional statistical software. Univariate and multivariate analysis will be performed. Chi-square test will be used for dichotomous variables, z-test/t-test or the Mann-Whitney U-test for continuous variables, as appropriate. Statistical significance if p <0.05.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Month
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult Undergoing Elective Cardiac Surgery
Key inclusion criteria (4 listed)
- Age > 18 years old
- Ability to provide an informed consent
- Planned cardiac surgery with median sternotomy and bi-pulmonary ventilation
- patients scheduled for adult elective cardiac surgery, performed with CPB and aortic cross-clamping.
Key exclusion criteria (7 listed)
- Patient refusal to provide informed consent
- Emergency surgery
- Cardiac surgery with TAVI/MitraClip
- Planned thoracotomy with one lung ventilation
- Patients with chronic kidney insufficiency (defined as dialysis)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Expiratory Flow Limitation
Time frame: Through study completion, an average of 24 hours after surgery
Incidence of Driving Pressure
Time frame: Through study completion, an average of 24 hours after surgery
6 secondary outcomes
Postoperative pulmonary complication
Time frame: Through study completion, an average of 7 days after surgery
ICU length of stay
Time frame: Through study completion, an average of 24 hours after surgery
Hospital length of stay
Time frame: Through study completion, an average of 7 days after surgery
Duration of mechanical ventilation
Time frame: Through study completion, an average of 7 days after surgery
PaO2/ FiO2
Time frame: Through study completion, an average of 24 hours after surgery
Mortality
Time frame: Through study completion, an average of 7 days after surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 May 2017.
- Background: PubMed 27875410Grieco DL, Chen L, Dres M, Brochard L. Should we use driving pressure to set tidal volume? Curr Opin Crit Care. 2017 Feb;23(1):38-44. doi: 10.1097/MCC.0000000000000377.
Related trials for Respiratory Failure
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Not yet recruiting
Regional Lung Ventilation During Prone Position in in Intubated Children
Pediatric Acute Respiratory Failure
Not yet recruiting
Smartphone Camera Measurement of Breathing-Related Heart Rate Variability Compared With ECG in Healthy Adults
Respiratory Sinus Arrhythmia, Heart Rate Variability
Not yet recruiting
Mechanical Ventilator Adjustments and Patient Dyspnea
Respiratory Failure, Dyspnea During Mechanical Ventilation
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Elena Bignami, MD principal investigator
Ospedale San Raffaele
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Respiratory Failure and Pneumothorax, run by Ospedale San Raffaele at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 May 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Expiratory Flow Limitation (time frame: Through study completion, an average of 24 hours after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03064659, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2017.